Letter sent to NCAA President Mark Emmert

June 30, 2022

Mr. Mark Emmert, President
National Collegiate Athletic Association
700 W. Washington Street
Indianapolis, IN 46206

Dear Mr. Emmert,

We are writing to notify you of letters that were recently mailed to thousands of college and university leaders, trustees, and responsible officials across the country, and to request action on behalf of hundreds of thousands of NCAA student-athletes. We have enclosed a sample of this letter addressed to the President of Georgetown University, who also serves as the chair of your Board of Governors.

The NCAA’s leadership and governance were critical in the Fall of 2021, when competitive sports resumed and a nationally televised college football season created a sense of normalcy for the country. The 2022 men’s and women’s NCAA basketball tournaments were equally thrilling for student-athletes, participating institutions, and millions of fans. Hundreds of thousands of parents were excited to see their student-athletes resume competition across all 24 NCAA sports last year. While it was sad to see some institutions insist on extreme protocols–as others truly returned to normal–the NCAA’s decision-making is commendable. We implore you to now exert the same influence  and leadership by addressing dangerous and discriminatory Covid-19 vaccination policies and practices that continue to exist at many NCAA institutions.

More than 100,000 student-athletes will soon be entering college for the first time, and some will be required to undergo Covid-19 vaccination or booster shots as a requirement for attendance. Many have already contracted and recovered from Covid-19, remain unvaccinated, and would choose to forgo this procedure if given the choice. It is concerning that many NCAA participating institutions are not allowing choice on the matter. Based on current adverse reaction data, it is statistically certain that a number of these new student-athletes will be harmed by the current products. We are also aware that some of the returning NCAA student-athletes –who were required to take Covid-19 vaccination or boosters due to 2021-2022 mandates–have experienced significant adverse reactions. Further investigation into the extent of these reactions and their long-term impact on athletic performance is essential.

Most recruited student-athletes signed National Letters of Intent (NLI) to commit to their universities, and it is unethical to require an invasive, irreversible, experimental medical procedure (not described in the NLI) as a condition of individual or team participation and competition. We recognize that the mandates are not imposed by the NCAA, but rather by a subset of NCAA participating institutions. However, student-athletes are legally bound to an institution via NCAA’s recruitment and commitment processes and regulations. In many cases, student-athletes are informed of mandates long after they have obligated themselves via NLI, and the student-athlete is in no position to stand up to college and university administrators, athletic directors, and coaches who hold enormous power over recruited athletes and their scholarships. This leads to unethical coercion and sets dangerous precedent. Given what numerous studies have revealed about adverse events in young people associated with these products (myocarditis and pericarditis being of special concern in athletes), it is clear that that any Covid-19 vaccination decisions must be left to the individual student-athlete and NOT the institution, its athletic director, or the coaching staff. 

Unvaccinated student-athletes at some NCAA institutions have been discriminated against with additional testing, masking, distancing, or transportation requirements. The pressure to conform can be intense, and there is concern about impacts to mental health when bodily autonomy is threatened, or when unvaccinated student-athletes are shamed because of their individual and personal medical decisions. Continued disparate treatment, based on Covid-19 vaccination status, must be stopped immediately. 

We now know that the currently available products do not stop infection or transmission, and there are reports that the National Football League is suspending its surveillance testing program.  We believe that the NCAA has the power–and a legal obligation–to take immediate action in the three areas described below.  In light of the recent findings described in our enclosed letter, failure to act may not only risk the reputation of your organization but could also invite lawsuits from vaccine-injured student-athletes. The NCAA is now on notice of this information.

Our requested course of action is as follows:
1) Investigate the number of vaccine or booster-related injuries and negative performance outcomes across all NCAA sports. Your Committee on Competitive Safeguards and Medical Aspects of Sports should engage directly with coaches and student-athletes and allow for anonymous reporting of negative outcomes observed at the coach/trainer/athlete level. How many student-athletes have lost a season to vaccine or booster-related complications? How many can no longer perform at the same level? The answers to these questions are essential for your organization and the public to know.

2) Issue guidance to all participating NCAA institutions that will put an end to discrimination based on Covid-19 vaccination status. It was wrong to require unvaccinated student-athletes to distance themselves from teammates, undergo rigorous unnecessary testing or masking (often as a form of punishment), or be excluded from certain team activities. The vaccines and boosters have not stopped transmission, and these practices at some institutions have caused significant harm to the mental health of students who may have been exempted for valid religious/medical/other reasons. After your guidance is released, consider investigating any vaccination and booster discrimination via the NCAA Infractions Process.

3) If you are unable to stop discrimination at the institutional level, immediately implement a process for student-athletes to find admittance at a school that will honor their individual choices related to vaccines or boosters. Some incoming freshmen and returning student-athletes are still unaware of how their school will be mandating vaccination for 2022-2023. If a student-athlete learns of a new or continuing mandate (with some institutions requiring booster after booster with no apparent end), that student-athlete should be allowed to immediately pursue another athletic opportunity at a non-mandate school. NLI’s should be voided, and scholarship allocations should be allowed to follow the athlete. If a student-athlete is required to transfer on the basis of a vaccine or booster mandate, the NCAA should not count that scholarship towards the normal Division I and II limit for the sport at the gaining institution. Special expedited admissions processes would also be required for this subset of student-athletes who need to find a new school quickly.

We thank you for your leadership, and request urgent attention to this serious matter.

Yours truly,

No College Mandates

No College Mandates is a coalition of thousands of concerned students, parents, professors, staff, and community members working to end college Covid-19 vaccination mandates and restore medical choice on college campuses.

Encl: Letter to Georgetown University President John DeGioia dated May 18, 2022


NCAA Leadership
Stan Wilcox, Executive Vice President of Regulatory Affairs
Scott Bearby, Senior Vice President of Legal Affairs and General Counsel
Brian Hainline, Senior Vice President and Chief Medical Officer
Felicia Martin, Senior Vice President of Inclusion, Education & Community Engagement
Kathleen McNeely, Senior Vice President of Administration and Chief Financial Officer
Cari Van Senus, Senior Vice President of Governance, Policy and Human Resources
Bob Williams, Senior Vice President of Communications
Jon Duncan, Vice President of Enforcement
Kevin Lennon, Vice President of Division I
Terri Steeb Gronau, Vice President of Division II
Louise McCleary, Vice President of Division III
Derrick Crawford, Vice President of Hearing Operations

Board of Governors/Division I Board of Directors
Shane Lyons, West Virginia University, Athletic Director
Sean Buck, U.S. Naval Academy
Kelly Damphousse, Arkansas State University, Chancellor
Randy Woodson, North Carolina State University, Chancellor
Rebecca Blank, University of Wisconsin-Madison, Chancellor
Geoff Mearns, Ball State University, President
Jere Morehead, University of Georgia, President
Linda Livingstone, Baylor University, President
Michael Schill, University of Oregon, President
David Wilson, Morgan State University, President
Philip Oldham, Tennessee Technological University, President
James Harris, University of San Diego, President
John DeGioia, Georgetown University, President
John Fry, Drexel University, President
Jeri Beggs, Illinois State University, FAR
Christopher Pietruszkiewicz, University of Evansville, President
Guy Bailey, The University of Texas Rio Grande Valley, President
Ken Chenault, General Catalyst
Robert Gates, William & Mary
Troy Hammond, North Central College, President
Grant Hill, Atlanta Hawks
Gayle Hutchinson, California State University, Chico, President
James Schmidt, University of Wisconsin-Eau Claire, Chancellor
Steven Shirley, Minot State University, President
Neal Smatresk, University of North Texas, President
Jim Johnson, Pittsburg State University, AD
Michelle Morgan, John Carroll University, Director of Athletics

Committee on Competitive Safeguards and Medical Aspects of Sports
Patrick Chun, Washington State University, AD
Kim Terrell, University of Oregon
Auburn Weisensale, University of Pittsburgh
Pam Hinton-Bruzina, University of Missouri, Columbia
James Houle, The Ohio State University
Luis Feigenbaum, University of Miami
Stephanie Chu, University of Colorado, Boulder
Deena Casiero, University of Connecticut
Buddy Teevens, Dartmouth College
Alan Hirahara, California State University, Sacramento
N. Jeremi Duru, American University
Nadine Mastroleo, Binghamton University
Cody Shimp, St. Bonaventure University
Richard Hendricks, Shorter University
Julie Rochester, Northern Michigan University
Tim Singleton, Wingate University
Wiley Cain, Kentucky Wesleyan College
Douglas Zipp, Ohio Wesleyan University
Michelle Walsh, Vassar College
Nicole Pieart, Lake Forest College
Talia Williams, Carleton College
Bob Colgate, National Federation for State High School Assoc.
Yolanda Malone-Gilbert, Independent

Directors of Athletics
Dave Heeke, University of Arizona
Ray Anderson, Arizona State University
Jim Knowlton, University of California, Berkeley
Martin Jarmond, University of California, Los Angeles
Rick George, University of Colorado
Rob Mullens, University of Oregon
Scott Barnes, Oregon State University
Mike Bohn, University of Southern California
Bernard Muir, Stanford University
Mark Harlan, University of Utah
Jennifer Cohen, University of Washington
Patrick Chun, Washington State University
Scott Stricklin, University of Florida
Josh Brooks, University of Georgia
Mitch Barnhart, University of Kentucky
Desiree Reed-Francois, University of Missouri
Danny White, University of Tennessee
Ray Tanner, University of South Carolina
Candice Storey Lee, Vanderbilt University
Greg Byrne, University of Alabama
Hunter Yurachek, University of Arkansas
Allen Green, Auburn University

Scott Woodward, Louisiana State University
Keith Carter, University of Mississippi
John Cohen, Mississippi State University
Ross Bjork, Texas A&M University
Joe Manhertz, St. Bonaventure University
Gerald Young, Carleton College
Doug Gillin, Appalachian State University
Jared Benko, Georgia Southern University
Charlie Cobb, Georgia State University
Scott McDonald, University of Louisiana Monroe
Joel Erdmann, University of South Alabama
Don Coryell, Texas State University
Brent Jones, Troy University
George Lee, University of Arkansas at Little Rock
Tyler Mariucci, California Baptist University
Cindy Goodman, California State University, Bakersfield
Jessica Poole, Chicago State University
Brandon Martin, University of Missouri-Kansas City
Mario Moccia, New Mexico State University
Shaney Fink, Seattle University
Chasse Conque, The University of Texas Rio Grande Valley
Jared Sumsion, Utah Valley University
Brandon Martin, University of Missouri-Kansas City
Mario Moccia, New Mexico State University
Shaney Fink, Seattle University
Chasse Conque, The University of Texas Rio Grande Valley
Jared Sumsion, Utah Valley University
Derrick Gragg, Northwestern University
Mike Bobinski, Purdue University
Chris McInstosh, University of Wisconsin – Madison
Mack Rhoades, Baylor University
Jamie Pollard, Iowa State University
Travis Goff, University of Kansas
Gene Taylor, Kansas State University
Joe Castiglione, University of Oklahoma
Chad Weiberg, Oklahoma State University
Jeremiah Donati, J.D., Texas Christian University
Chris Del Conte, University of Texas at Austin
Kirby Hocutt, Texas Tech University
Shane Lyons, West Virginia University
Randale Richmond, Kent State University
David Saylor, Miami University
Julie Cromer, Ohio University
Bob Moosbrugger, Bowling Green State University
Mark Alnutt, University at Buffalo
Charles Guthrie, University of Akron
Sean Frazier, Northern Illinois University
Amy Folan, Central Michigan University
Bryan Blair, University of Toledo
Beth Goetz, Ball State University
Scott Wetherbee, Eastern Michigan University
Dan Bartholomae, Western Michigan University
John Hartwell, Utah State University
Nathan Pine, US Air Force Academy
Jeramiah Dickey, Boise State University
Tom Burman, University of Wyoming
Joe Parker, Colorado State University
Eddie Nunez, University of New Mexico
John Wicker, San Diego State University
Terry Tummy, Fresno State
Stephanie Rempe, University of Nevada
Jeff Konya, San Jose State University
David Matlin, University of Hawai’i at Manoa
Erick Harper, UNLV
Chris Kenny, St Michael’s College
Jeff Purinton, Arkansas State University
Matt Hogue, Coastal Carolina University
Bryan Maggard, University of Louisiana at Lafayette
Jamie Boggs, Grand Canyon University
Lisa Campos, University of Texas San Antonio

Enclosure: Letter to Georgetown University President John DeGioia dated May 18, 2022

May 18, 2022

Sent via certified mail and email to

Dr. John DeGioia, President
Georgetown University
204 Healy Hall Hall
Washington, DC 20057

Dear Dr. DeGioia,

We are writing to notify you of recently available information prompting concern that fraud has been committed by Pfizer and by the FDA in the development and continued distribution of Pfizer’s Covid-19 vaccine. Given that Georgetwon University mandates Covid-19 vaccination for students as a condition of enrollment, it is incumbent upon you to be fully informed about the safety and efficacy of these vaccines and the claims of fraud that call both into question.

If fraud or willful misconduct is proven, the manufacturers and those involved in the distribution or mandating of the vaccines will lose immunity from liability granted to them under the existing EUA and the PREP act.

We urge you to further investigate. We believe that once you do, you will see how continued Covid-19 vaccine mandates jeopardize the safety of your students and the reputation of your institution.

The new information consists of Pfizer’s biological product file used to obtain FDA approval of Comirnaty and data from the insurance industry showing a huge rise in excess deaths in Millennial and Gen X populations concurrent with the implementation of vaccine approvals and mandates. The excess death data is raising concerns in the insurance industry and on Wall Street. We are also including timely news about product safety, given the FDA’s recent restriction of the Johnson & Johnson vaccine due to blood clotting concerns.

Below we give a brief overview of each category and starting points for further inquiry. We are standing by to provide you with additional information or to connect you to scientists, lawyers and investors who are reviewing the current and evolving data.

Pfizer Biological Product File – background and highlights:

The Public Health and Medical Professionals for Transparency (PHMPT) is a nonprofit group made up of public health professionals, medical professionals, scientists, and journalists. The group exists solely to obtain and disseminate the data relied upon by the FDA to license Covid-19 vaccines. Four days after the Pfizer Covid-19 vaccine was approved for children over 16, this group submitted a Freedom of Information Act for all data within Pfizer’s Covid-19 vaccine biological product file. When the FDA asked for 75 years to release that data, PHMPT sued to obtain it and won. Beginning in March 2022, the public has access to Pfizer’s clinical trial data, which is being downloaded in batches monthly. You can find the document releases to-date here.

Thousands of volunteers including scientists, statisticians, doctors, and lawyers continue to examine these downloads and publish their findings. For ready reference, below are just a few of the findings of greatest concern that call into question the safety and efficacy of the Pfizer product and support a thesis of fraud:

  • Pfizer failed the all-cause mortality endpoint in their unprecedentedly short 28-day clinical trial. In brief, more people died in the vaccinated group than in the placebo group. This was known yet has still not been widely disclosed to the public.
  • The CDC talking point that vaccines stopped transmission was based on no data, as this metric was not evaluated during Pfizer’s clinical trials. Pfizer and the FDA knew this yet did not disclose it to the public.
  • Pfizer and the FDA knew as early as November 2020 that Pfizer’s clinical trials showed
    • Vaccine failure
    • Waning vaccine efficacy
  • A baseline condition for granting a product Emergency Use Authorization is that it must be safe and effective. The data showed that the products are not effective. Yet, based on FDA approval, the CDC promoted them as such. From the initial roll-out in December 2020 through April 1, 2021, the public health messaging was that if you received the shot, you could not get infected and could not transmit the virus. The Pfizer documents are proof that they and the FDA colluded to lie to the American people and the CDC created false public health narratives based on these lies.
  • Pfizer and the FDA most likely knew in May 2021 that the vaccines caused heart damage in teenagers based on a paper that was already in peer review at that time. The FDA approved the product for teenagers in June 2021 yet did not disclose this risk factor to consumers until August. During that time, all those who received this product did not have informed consent. Parents were not made aware of this known potential risk to their children.
  • Brook Jackson, a regional director employed by Pfizer sub-contractor Ventavia Research Group, came forward in September 2020 with documented evidence that the company falsified data, unblinded patients and was slow to follow up on adverse events reported in Pfizer’s pivotal phase III trial conducted by Ventavia. Her findings call into question the integrity of not only Ventavia’s results but of all of the results from Pfizer’s other trial sites and the entire clinical trial. Further information is available in The British Medical Journal.

Excess death data and the insurance industry:
In December 2021, Midwest insurer One America CEO Scott Davidson disclosed a 40% increase in excess deaths over pre-pandemic levels in the working-age (18-64) population in the third quarter. Putting the number into context Davidson said, “The data is consistent across every player in this business . . . Just to give you an idea of how bad that is, a three-sigma or a one-in-200-year catastrophe would be a 10 percent increase over pre-pandemic. So 40 percent is just unheard of”. Other major insurers have subsequently reported increases in death claims ranging from 21–57 % over expected levels. Most of these deaths are not Covid-19 deaths. Long-term disability claims are also seeing an uptick.

These reports prompted a former institutional investor who was a #1 ranked Wall Street sell-side insurance analyst to confirm the numbers using CDC reported data. His findings, independently confirmed by others, show the spikes in excess deaths are related to the timing of vaccine approvals and mandates. This data is prompting concern at insurance and reinsurance companies, who will bear the financial brunt of this unexpected and unprecedented rise in mortality. It is raising questions about the safety of the Covid-19 vaccines in the investment community and beyond.

Of related interest is Pfizer’s amendment in February of its business risk disclosures in its Q4 2021 earnings report. The changes from the Q3 2021 report language center around disclosures of unfavorable safety data and “further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection”.

It is likely that neither Pfizer nor the FDA anticipated the court-compelled release of their clinical trial and post-marketing surveillance data and the subsequent public scrutiny of it.

Additional product safety concerns:

The FDA announced on May 5 that they were restricting use of the Johnson & Johnson Covid-19 vaccine due to the risk of thrombosis with thrombocytopenia syndrome (TTS), a syndrome of rare and potentially life-threatening blood clots in combination with low levels of blood platelets. The decision to restrict was based on 60 reported cases and 9 fatalities. The Pfizer and Moderna vaccines also have serious risks and fatalities associated with them including but not limited to blood clots and myocarditis in college-aged populations. These are shown in Pfizer’s post-marketing surveillance data and in the CDC’s Vaccine Adverse Event Recording System (VAERS). As of April 29, 2022, there were approximately 1.2 million reports of adverse events following Covid-19 vaccination including more than 18,056 reports of deaths following the Pfizer vaccine, and 7,223 following the Moderna vaccine. Logic demands that Pfizer and Moderna products be restricted immediately as well. Why have they not been? Further, a recent Danish review of all three products in preprint in The Lancet showed that the J&J reduced all-cause mortality but that Pfizer and Moderna did not and may have increased it. Given all this, it is reasonable to think that Pfizer and Moderna products could be restricted or discontinued very soon due to safety concerns. This might well trigger a much higher level of scrutiny of the now-publicly available Pfizer data and the actions of our public health institutions. How would such a situation impact institutions such as yours that continue to mandate the products while knowing such risks exist?

One last thing to consider is the nature and associated secrecy of the contracts that Pfizer forced upon governments as conditions of sale and distribution of their Covid-19 vaccines in their respective countries. A review of some of these contracts can be found here. Terms included such things as the waiving of sovereign immunity, countries assuming full liability in the event that Pfizer was shown to have used another entity’s intellectual property, and that Pfizer be held harmless in the event of injury or death from the products. Why would a company require such terms if it knew its conduct and its products were sound?

We trust this information has been useful and that you will investigate this matter fully. We urge you to end your vaccine mandates to protect Georgetown University’s students, reputation, and, in the event that fraud is proven, potentially your endowment.

Yours truly,

No College Mandates

No College Mandates is a coalition of thousands of concerned students, parents, professors, staff, and community members working to end college Covid-19 vaccination mandates and restore medical choice on college campuses.

Health Freedom Defense Fund

Health Freedom Defense Fund is a 501(c)(3) non-profit which seeks to protect and advance health freedom, educate Americans on informed consent, advocate for human rights and bodily autonomy for all people, and legally challenge unethical mandates, laws, and policies when necessary.

cc. Joseph Ferrara
Robert Groves
Thomas Reynolds III
Marie Mattson
Joseph Yohe
Adam Adler
Dr. Andria Wisler
Thomas Reynolds
Suzanne Donohoe
Sr. Carol Keehan
Rosemary Berkery
Joseph Baratta
W. Robert Berkery, Jr.
Bruce Blume
Frank Ciatto
Kevin Clark
Mary Erdoes
Thomas Farley
Bonnie Gwin
Amy Goldman
Kaya Henderson
Tyree Jones
Sonny Kalsi
Fr. James McCourt
Frank Martin
Dikembe Mutombo
James O’Hara
Michael Psaros
Thomas Purcell
Melody Rollins
Jeanne Ruesch
Kenneth Samet
Ann Sarnoff
Kevin Warren

No responses yet

Leave a Reply

Your email address will not be published. Required fields are marked *